United States

Immune Design Corp (IMDZ.OQ)

IMDZ.OQ on NASDAQ Stock Exchange Global Market

13 Nov 2018
Change (% chg)

$-0.02 (-1.45%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Edward Penhoet

77 2013 Independent Chairman of the Board

Carlos Paya

58 2011 President, Chief Executive Officer, Director

Stephen Brady

47 2015 Executive Vice President, Strategy & Finance

Sergey Yurasov

48 2016 Senior Vice President, Clinical Development, and Chief Medical Officer

Jan Ter Meule

54 2013 Chief Scientific Officer